Clinical Trials Market Forecast
The global clinical trials market is valued at USD 90.1 billion in 2025 and is projected to surpass USD 123.5 billion by 2030, growing at a CAGR of 6.51%.
North America holds a commanding position in the clinical trials market due to robust pharma-biotech investment, mature regulatory frameworks, and a dense network of CRO and site infrastructure.
The Asia-Pacific region is emerging as the fastest-growing market, driven by expanding treatment-naïve populations, rising clinical-research capacity in China and India, and the growing appeal of cost-efficient, hybrid trial models.
For more information, visit the Mordor Intelligence report for a full breakdown of market size, segmentation data, and competitive intelligence.
Driven by hybrid and decentralized trial adoption.
Author summary: Clinical trials market grows 6.51% CAGR to 2030.